Gulmay Medical Ltd


Company: Gulmay Medical Ltd
Website Address: www.gulmaymedical.com
Compant Contacts:
Martin Robinson – Managing Director martinrobinson@gulmaymedical.com
Amanda Tulk – Business Development Director amandatulk@gulmaymedical.com
Adrian Treverton – Sales Director adriantreverton@gulmaymedical.com
Kirsti Gordon – Clinical Support kirstigordon@gulmaymedical.com

Feature Article
Gulmay Medical has been designing and manufacturing medical and scientific equipment for over fifteen years and have world class X-ray therapy systems in more than 400 clinics worldwide.
We manufacture a range of specialist Superficial and Orthovoltage X-ray therapy Systems covering the entire X-ray spectrum from Grenz Ray to Orthovoltage energy ranges. System features include integrated dosimetry, encoded filter and applicator recognition, DICOM connectivity and Patient Data, Record and Verify Systems.  The Xstrahl 100 The newest addition to the range is the Xstrahl 100 a dedicated low energy Superficial X-ray Therapy System (10-100kV).


The compact design of the Xstrahl 100 system enables maximum manoeuvrability and unrestricted applicator positioning, allowing treatment of common superficial lesions and dermatological conditions

The XSTRAHL 100 system has a unique integrated filter design with fully encoded applicators ensuring safety in filter and applicator selection. The compact design enables maximum manoeuvrability of the treatment head with a single button release electromagnetic break, allowing the machine to be accurately positioned quickly and effortlessly with one hand.

Edinburgh Royal Infirmary is the first UK site to receive the Xstrahl 100 System. Dr Hamish Porter Deputy Head of Medical Physics reported;

“Our first impression of the 100kV superficial unit was how neat and small it was. We intend using this unit exclusively for a skin therapy service and want the general impression of the equipment to be as patient friendly as possible. The installation took only 2 days and went extremely well and commissioning began immediately after that, so far we have found it very straightforward to use.”






At the ESTRO meeting in Barcelona Gulmay Medical Ltd launched STEP an educational programme to raise awareness and support the use of superficial and Orthovoltage X-ray therapy worldwide.

STEP (superficial therapy educational programme) is an invaluable source of information for oncology and dermatology professionals and is an educational resource aimed at increasing awareness of this essential treatment modality.

The programme has been developed by the STEP clinical advisory panel, a team of UK Radiotherapy and Oncology experts.
STEP addresses the following key topic areas:
• Overview and history of X-rays
• Physics of low energy radiation
• Malignant and benign conditions suitable for treatment with low energy X-rays
• Standard UK treatment regimes • Treatment set up and treatment accessories
• Patient care during and after treatment
For further information on the STEP programme or to request a copy of the educational CD ROM please contact Kirsti Gordon – Clinical Support. e-mail: kirstigordon@gulmaymedical.com

News
At the ESTRO meeting in Barcelona Gulmay Medical Ltd launched STEP, an educational programme to raise awareness and support the use of superficial and Orthovoltage X-ray therapy worldwide. The programme is aimed at increasing awareness of this essential treatment modality. For further information please visit

http://www.gulmaymedical.com/step/ or contact Kirsti Gordon on kirstigordon@gulmaymedical.com

AMC Symposium
Adrian Treverton and Kirsti Gordon from Gulmay Medical Ltd recently gave two presentations at the Superficial and Orthovoltage Therapy symposium at the Academic Medical Centre in Amsterdam in January. The meeting was attended by around 30 Radiotherapy and Oncology professionals from across Holland and addressed issues including the use of Superficial and Orthovoltage X-ray therapy in modern Radiotherapy.

Gulmay Medical Ltd now has over 400 systems installed worldwide. Recent UK installations include an Xstrahl 200 system at Poole Hospital NHS Foundation Trust whilst Edinburgh Cancer Centre is the first UK department to receive the Xstrahl 100 system. Further afield, we currently have several installations underway in both America and Canada.

Upcoming events:
The ESTRO meeting in Goteborg, Sweden. 14th – 18th September 2008 The ASTRO meeting in Boston. 21st-25th September 2008